Perspective Therapeutics, Inc
Price
FilingsNewest: 8-K, Other eventsOct 1 →Insiders2 insiders bought $42,276 in 2 open-market buys. No sales.→HoldersBlackRock 8.3%TCG Crossover 6.9%Commodore Capital 5.6%→Financing →PeersClosest companies: AKTS, SLS, INTS→
From the filings
Figures
- Net income
- −$116.4Mlast 12 months
- Operating cash flow
- −$92.4Mlast 12 months
- Cash and equivalents
- $48.5Mat the last balance sheet
- Total debt
- $1.6Mat the last balance sheet
- Shares outstanding
- 114.1M shareson issue